Gene · 50848
Papers3,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YouTube as a Source of Patient Information for Meningiomas: A Content Quality and Audience Engagement Analysis. | Healthcare (Basel) | 2022 | 35326984 | PubTator, text mining | PubMed |
| The Role of CD200-CD200 Receptor in Human Blood and Lymphatic Endothelial Cells in the Regulation of Skin Tissue Inflammation. | Cells | 2022 | 35326506 | PubTator, text mining | PubMed |
| A CRISPR-Cas9 screen reveals a role for WD repeat-containing protein 81 (WDR81) in the entry of late penetrating viruses. | PLoS Pathog | 2022 | 35320319 | PubTator, text mining | PubMed |
| Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome. | Neurogastroenterol Motil | 2022 | 35315179 | PubTator, text mining | PubMed |
| Paip2A inhibits translation by competitively binding to the RNA recognition motifs of PABPC1 and promoting its dissociation from the poly(A) tail. | J Biol Chem | 2022 | 35307347 | PubTator, text mining | PubMed |
| Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism. | Bioengineered | 2022 | 35300558 | PubTator, text mining | PubMed |
| New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease. | Front Pediatr | 2022 | 35299671 | PubTator, text mining | PubMed |
| Effect of F11R Gene Knockdown on Malignant Biological Behaviors of Pancreatic Cancer Cells. | J Oncol | 2022 | 35295710 | PubTator, text mining | PubMed |
| Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. | Oncoimmunology | 2022 | 35295096 | PubTator, text mining | PubMed |
| A JAM-A-tetraspanin-αvβ5 integrin complex regulates contact inhibition of locomotion. | J Cell Biol | 2022 | 35293964 | PubTator, text mining | PubMed |
| Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins. | Sci Rep | 2022 | 35292710 | PubTator, text mining | PubMed |
| NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma. | Mol Ther Oncolytics | 2022 | 35284625 | PubTator, text mining | PubMed |
| Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches. | Front Pharmacol | 2022 | 35281942 | PubTator, text mining | PubMed |
| How Does the Immune System Enter the Brain? | Front Immunol | 2022 | 35273596 | PubTator, text mining | PubMed |
| Overview of the Importance of Biotics in Gut Barrier Integrity. | Int J Mol Sci | 2022 | 35270039 | PubTator, text mining | PubMed |
| CFTR, Cell Junctions and the Cytoskeleton. | Int J Mol Sci | 2022 | 35269829 | PubTator, text mining | PubMed |
| Proteolytic Landscapes in Gastric Pathology and Cancerogenesis. | Int J Mol Sci | 2022 | 35269560 | PubTator, text mining | PubMed |
| Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression. | Cancers (Basel) | 2022 | 35267611 | PubTator, text mining | PubMed |
| Astrocytic junctional adhesion molecule-A regulates T-cell entry past the glia limitans to promote central nervous system autoimmune attack. | Brain Commun | 2022 | 35265839 | PubTator, text mining | PubMed |
| Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells. | Theranostics | 2022 | 35265199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50848/papers?page=50